You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Droxidopa - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for droxidopa and what is the scope of freedom to operate?

Droxidopa is the generic ingredient in two branded drugs marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Annora, Aurobindo Pharma Ltd, Bionpharma, Bluepharma Industria, Chartwell Rx, Hikma, Lupin Pharms, Msn Pharms Inc, Sciegen Pharms Inc, Slate Run Pharma, Sun Pharm, Teva Pharms Usa Inc, Upsher Smith Labs, Zydus Pharms, and Lundbeck Na Ltd, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for droxidopa. Sixteen suppliers are listed for this compound.

Summary for droxidopa

US Patents:	0
Tradenames:	2
Applicants:	17
NDAs:	17
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	95
Clinical Trials:	34
Patent Applications:	761
Drug Prices:	Drug price trends for droxidopa
What excipients (inactive ingredients) are in droxidopa?	droxidopa excipients list
DailyMed Link:	droxidopa at DailyMed

See drug prices for droxidopa

Recent Clinical Trials for droxidopa

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Kessler Foundation	Phase 4
H. Lundbeck A/S	Phase 2
Loma Linda University	Phase 2

See all droxidopa clinical trials

Pharmacology for droxidopa

Physiological Effect	Increased Blood Pressure

Medical Subject Heading (MeSH) Categories for droxidopa

Antiparkinson Agents

Anatomical Therapeutic Chemical (ATC) Classes for droxidopa

C01CA	Adrenergic and dopaminergic agents
C01C	CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01	CARDIAC THERAPY
C	Cardiovascular system

US Patents and Regulatory Information for droxidopa

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Annora	DROXIDOPA	droxidopa	CAPSULE;ORAL	211726-003	Aug 9, 2021	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Sun Pharm	DROXIDOPA	droxidopa	CAPSULE;ORAL	214384-003	Feb 18, 2021	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva Pharms Usa Inc	DROXIDOPA	droxidopa	CAPSULE;ORAL	213162-002	Feb 18, 2021		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.